The North End Water Pollution Control Centre (NEWPCC) in Manitoba, Canada serves a population of approximately 380,000. The dry weather flow to the NEWPCC is approximately 175 ML/d (46 MGD). The plant uses anaerobic digestion and centrifuge dewatering in its solids treatment train. The centrate stream comprises approximately 20 percent of the plant's phosphorus load. The plant suffers from severe struvite (magnesium ammonium phosphate) deposition: centrifuges and centrate piping have to be regularly cleaned. The Province requires that the plant control the phosphorus load recycled in the centrate: the total phosphorus (TP) load must not exceed 119 kg/d, as determined by a thirty day rolling average. In order to meet the requirements of the Province, and to control struvite, a metal salt will be dosed into the digested sludge, upstream of the centrifuges. Prior to design of a metal salt dosing system, a full-scale trial was initiated. Two potential metal salts were identified; ferric chloride (FeCl 3 ) and aluminum sulphate or alum (Al 2 (SO 4 ) 3 ·14H 2 O).
INTRODUCTION
Manitoba Conservation issued a new licence in June, 2005 which provides the operating requirements of the NEWPCC in Winnipeg, Manitoba. The licence stipulates that the centrate from the sludge dewatering facility should have a TP load that does not exceed 119 kg/d, as determined by a thirty day rolling average. In order to meet the requirements of the licence, it is proposed that phosphorus be removed from the centrate stream and directed to the biosolids stream, by the dosing of a metal salt into the sludge. Two potential metal salts were identified; ferric chloride (FeCl 3 ) and aluminum sulphate or alum (Al 2 (SO 4 ) 3 ·14H 2 O).
Struvite is magnesium ammonium phosphate (MAP) and has the chemical formula of MgNH4PO4·6H2O. Struvite is commonly found in wastewater treatment plants that have anaerobic digesters. Struvite forms when the chemical constituents reach levels of Since phosphate is a key constituent of struvite, removal of phosphate could reduce the potential for struvite precipitation. Therefore, the removal of phosphorus from the centrate stream, could reduce the quantity of struvite deposited in the piping and centrifuges.
Due to the risk that struvite deposition in the centrate pipes could get worse with the implementation of BNR, phosphorus removal options for the centrate treatment project should consider the benefits of phosphorus removal in a manner that reduces unwanted struvite formation.
In order to verify that a metal salt could remove phosphorus from the centrate, it was agreed that jar-tests would be undertaken on the liquid digested sludge. Preliminary jar-tests were undertaken using ferric chloride and alum prior to the full-scale trials. After addition of the chemical, each sample was centrifuged and filtered. Results were positive indicating that the phosphorus concentration in filtered sludge samples could be reduced by metal salt dosing. It was found that at an alum dose rate of approximately 130 mg/L (as Al), approximately 70 percent of the phosphate was removed. For ferric chloride, it was found that at a dosage of approximately 360 mg/L (as Fe), approximately 75 percent of the phosphate was removed. Although jar-tests are valuable in evaluating metal salt dosing rates they are often not directly comparable to the full-scale environment due to differing conditions (e.g. mixing intensity, reaction time and dewatering efficiency). This paper presents the results of the full-scale trials using ferric chloride and alum conducted in April and May of 2005 in order to estimate the optimal dose rates and to assess which metal salt is better suited for phosphorus removal at the NEWPCC. An additional goal was to investigate if struvite formation in the centrate could be controlled with the addition of these metal salts.
EXPERIMENTAL SET-UP
The full-scale trials involved the dosing of metal salts into the centrifuge feed piping. This arrangement allowed a dose-response relationship to be established relatively quickly. A solution containing 48.4 percent alum and 31.0 percent ferric chloride was used for the full-scale phosphorus removal trial. Figure 1 illustrates the dosing point for the trials.
The chemicals were manufactured by Eaglebrook Inc. and supplied in 1,000 litre totes. The chemical in the tote was injected using a dosing pump skid and connecting hoses, both of which were supplied by Eaglebrook. The metal salts were injected into the discharge piping of the centrifuge sludge feed pump. To facilitate mixing of the metal salt with the sludge, an existing section of vertical steel piping was removed and replaced with a PVC in-line mixer with integral dosing point and a PVC spool piece. A "miniberm" secondary containment system was installed around the dosing pump skid and tote. Figure 2 illustrates the arrangement of the secondary containment system and the chemical tote. 
TESTING PROTOCOLS
Two experiments were performed. In the first experiment, alum was added to the digested sludge. In the second experiment, ferric chloride was added to the digested sludge. In each experiment, three trials were performed. Table 1 summaries the dosing rates of the metal salts utilized in the trials. Each dose rate was maintained for 30 minutes during which three sets of samples of centrate and biosolids cake were collected (at 0, 10, and 30 minutes). The collected samples were then analyzed by the City for the parameters listed in Table 2 . Figure 3 illustrates the results of the full-scale alum trials. It was found that as the alum dose rate increased the concentration of TP in the centrate stream decreased and tailed off at approximately 10 to 20 mg/ L TP.
Alum Trials

Figure 3 -Changes in TP Concentration in Centrate Stream
Figure 4 -Percent Reduction in Crystal Concentration
Figure 4 present the concentration of crystals in the centrate. The crystals were not analyzed, but it is assumed that the crystals are struvite. As noted in the figure, the impact of the addition of alum to the centrate stream on the crystal concentration was significant. For instance, a low dose
Figure 5 -Microscope Photos of Centrate Crystals in Alum Trial
The changes in TSS concentration in the centrate stream are summarized in Figure 6 . As expected, the TSS concentration was reduced with the addition of alum due to its coagulant effect and the reduction in crystal concentration of the centrate. At a dose rate of approximately 60 mg/L (as Al), the concentration of TSS started to tail-off.
The pH changes in the centrate stream are summarized in Figure 7 . Struvite is least soluble at a pH of approximately 10. If the pH is above or below 10, the solubility of struvite increases. In the pH range shown in the figure, struvite solubility would be expected to increase as the dose rate of alum increased. Since there is a reduction in phosphorus content of the centrate and there is an increase in phosphorus content of the biosolids, the reduction in pH is likely not the cause of the reduction in the concentration of crystals; rather the reduction in crystals is due to the formation of aluminum phosphate which is removed with the biosolids cake. Figure 8 illustrates the results of the full-scale trials for ferric chloride. The results of Ferric Trial 1 showed that as the ferric chloride dose rate increased the concentration of TP in the centrate stream decreased. Of note, the second and third ferric chloride trials had centrate phosphorus concentrations initially reported as <0.05 mg/L at the high dose rates. These low concentrations were likely inaccurate due to the high dilution factors involved in the analytical procedure and the low concentrations of phosphorus in the samples. The samples were re-analyzed using a more appropriate dilution factor. The revised results were confounding in that the centrate phosphorus concentration increased after the dose of 273 mg/L. As illustrated in Figure 11 , the pH change in the centrate stream reduces as the concentration of ferric increases. However, as explained for the alum trials, it appears that the reduction in pH is not the cause for the reduction in concentration of crystals in the centrate. Figure 12 illustrates the Fe content in the biosolids cake. As the concentration of ferric chloride dose increased, the concentration of Fe in the biosolids cake increased in response to the addition of ferric chloride. Complete phosphorus mass balances were performed on the experimental data during the alum and ferric chloride full-scale trials. The results of the mass balance calculations are presented in Table 3 . The overall phosphorus balance closed to 105 percent, indicating data integrity. 
